BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang CM, Pu CW, Hou YH, Chen Z, Alanazy M, Hebbard L. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World J Gastroenterol 2014; 20(44): 16464-16473 [PMID: 25469014 DOI: 10.3748/wjg.v20.i44.16464]
URL: https://www.wjgnet.com/1007-9327/full/v20/i44/16464.htm
Number Citing Articles
1
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Zhizhen Dong, Dengfu Yao. Neoplasm2018;  doi: 10.5772/intechopen.77400
2
David W Russell, Markus Grompe. Adeno-associated virus finds its diseaseNature Genetics 2015; 47(10): 1104 doi: 10.1038/ng.3407
3
Keith Pereira, Jason Salsamendi, Javier Casillas. The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to KnowJournal of Clinical Imaging Science 2015; 5: 32 doi: 10.4103/2156-7514.157860
4
Yuji Ogawa, Masato Yoneda, Takashi Kobayashi, Yasushi Honda, Takaomi Kessoku, Kento Imajo, Satoru Saito, Atsushi Nakajima. Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adultsExpert Opinion on Pharmacotherapy 2019; 20(1): 69 doi: 10.1080/14656566.2018.1543403
5
Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Vimal Pandey, Jomon Joseph, Rajashekar Mohan, Praveen Kumar Shetty, Manoj Kumar Bhat. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4Scientific Reports 2016; 6(1) doi: 10.1038/srep27558
6
Cathrin Sellmann, Cheng Jun Jin, Anna Janina Engstler, Jean-Pascal De Bandt, Ina Bergheim. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD)European Journal of Nutrition 2017; 56(8): 2519 doi: 10.1007/s00394-016-1287-9
7
Teruhisa Higuchi, Mitsuhiko Moriyama, Akiko Fukushima, Hiroshi Matsumura, Shunichi Matsuoka, Tatsuo Kanda, Masahiko Sugitani, Akiko Tsunemi, Takahiro Ueno, Noboru Fukuda. Association of mRNA expression of iron metabolism-associated genes and progression of non-alcoholic steatohepatitis in ratsOncotarget 2018; 9(40): 26183 doi: 10.18632/oncotarget.25488
8
Paola Dongiovanni, Marica Meroni, Salvatore Petta, Miriam Longo, Anna Alisi, Giorgio Soardo, Luca Valenti, Luca Miele, Stefania Grimaudo, Grazia Pennisi, Grieco Antonio, Dario Consonni, Silvia Fargion, Anna Ludovica Fracanzani. Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLDBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(10): 158765 doi: 10.1016/j.bbalip.2020.158765
9
Paola Berenice Mass Sanchez, Marinela Krizanac, Ralf Weiskirchen, Anastasia Asimakopoulos. Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel InsightsInternational Journal of Molecular Sciences 2021; 22(10): 5284 doi: 10.3390/ijms22105284
10
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateWorld Journal of Gastroenterology 2015; 21(22): 6820-6834 doi: 10.3748/wjg.v21.i22.6820
11
R Díaz-Rúa, E M van Schothorst, J Keijer, A Palou, P Oliver. Isocaloric high-fat feeding directs hepatic metabolism to handling of nutrient imbalance promoting liver fat depositionInternational Journal of Obesity 2016; 40(8): 1250 doi: 10.1038/ijo.2016.47
12
Eman D. Mohammed, Ashraf B. Abdel-Naim, Jin Kangpeng, Runqiu Jiang, Jifu Wei, Beicheng Sun. The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventerLife Sciences 2021; 264: 118615 doi: 10.1016/j.lfs.2020.118615
13
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for managementWorld Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
14
Vasilios G Athyros. Statins for the Treatment of Non Alcoholic Fatty Liver Disease in Patients with Metabolic SyndromeJournal of Diabetes, Metabolic Disorders & Control 2016; 3(1) doi: 10.15406/jdmdc.2016.03.00057
15
Katharina Luise Hupa-Breier, Janine Dywicki, Björn Hartleben, Freya Wellhöner, Benjamin Heidrich, Richard Taubert, Young-Seon Elisabeth Mederacke, Maren Lieber, Konstantinos Iordanidis, Michael P. Manns, Heiner Wedemeyer, Matthias Hardtke-Wolenski, Elmar Jaeckel. Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASHBiomedicines 2021; 9(4): 353 doi: 10.3390/biomedicines9040353
16
Silvia Zappavigna, Daniela Vanacore, Stefania Lama, Nicoletta Potenza, Aniello Russo, Pasquale Ferranti, Marcello Dallio, Alessandro Federico, Carmelina Loguercio, Pasquale Sperlongano, Michele Caraglia, Paola Stiuso. Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma CellsInternational Journal of Molecular Sciences 2019; 20(9): 2190 doi: 10.3390/ijms20092190
17
Ben-Chen Rao, Jia-Min Lou, Wei-Jie Wang, Ang Li, Guang-Ying Cui, Zu-Jiang Yu, Zhi-Gang Ren. Human microbiome is a diagnostic biomarker in hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2020; 19(2): 109 doi: 10.1016/j.hbpd.2020.01.003
18
Hao-ran Ding, Jing-lin Wang, Hao-zhen Ren, Xiao-lei Shi. Lipometabolism and Glycometabolism in Liver DiseasesBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/1287127
19
Zhen-Ya Lu, Chao Cen, Zhou Shao, Xin-Hua Chen, Cheng-Fu Xu, You-Ming Li. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional studyWorld Journal of Gastroenterology 2016; 22(5): 1884-1890 doi: 10.3748/wjg.v22.i5.1884
20
C. Miethe, H. Nix, R. Martin, A. R. Hernandez, R. S. Price. Silibinin Reduces the Impact of Obesity on Invasive Liver CancerNutrition and Cancer 2017; 69(8): 1272 doi: 10.1080/01635581.2017.1367935
21
Pasquale Agosti, Carlo Sabbà, Antonio Mazzocca. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironmentBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(2): 607 doi: 10.1016/j.bbadis.2017.11.026
22
Konstantinos Kargiotis, Vasilios G Athyros, Olga Giouleme, Niki Katsiki, Evangelia Katsiki, Panagiotis Anagnostis, Chrysoula Boutari, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndromeWorld Journal of Gastroenterology 2015; 21(25): 7860-7868 doi: 10.3748/wjg.v21.i25.7860
23
Ali A. Mencin, Rohit Loomba, Joel E. Lavine. Caring for children with NAFLD and navigating their care into adulthoodNature Reviews Gastroenterology & Hepatology 2015; 12(11): 617 doi: 10.1038/nrgastro.2015.146
24
Catherine T. Frenette, Ari J. Isaacson, Irene Bargellini, Sammy Saab, Amit G. Singal. A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at RiskMayo Clinic Proceedings: Innovations, Quality & Outcomes 2019; 3(3): 302 doi: 10.1016/j.mayocpiqo.2019.04.005
25
Zhuanchang Wu, Hongxin Ma, Liyuan Wang, Xiaojia Song, Jie Zhang, Wen Liu, Yutong Ge, Yang Sun, Xiangguo Yu, Zehua Wang, Jianping Wang, Yankun Zhang, Chunyang Li, Nailin Li, Lifen Gao, Xiaohong Liang, Xuetian Yue, Chunhong Ma. Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptakeCell Death & Differentiation 2020; 27(5): 1693 doi: 10.1038/s41418-019-0453-z
26
Adriana R. Schultz Moreira, Sabrina Rüschenbaum, Stefan Schefczyk, Ulrike Hendgen-Cotta, Tienush Rassaf, Ruth Broering, Matthias Hardtke-Wolenski, Laura Elisa Buitrago-Molina. 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic HepatocytesInternational Journal of Molecular Sciences 2020; 21(21): 8279 doi: 10.3390/ijms21218279
27
Eman D. Mohammed, Zechuan Zhang, Wenfang Tian, Venkatanarayana Gangarapu, A.A. Al-Gendy, Jun Chen, Jifu Wei, Beicheng Sun. Modulation of IR as a therapeutic target to prevent NASH using NRF from Diceratella elliptica (DC.) jonsell. Strong Nrf2 and leptin inducer as well as NF-kB inhibitorPhytomedicine 2021; 80: 153388 doi: 10.1016/j.phymed.2020.153388
28
Kelli A. Lytle, Christopher M. Depner, Carmen P. Wong, Donald B. Jump. Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr mice by targeting the TGFβ-Smad3 pathwayJournal of Lipid Research 2015; 56(10): 1936 doi: 10.1194/jlr.M061275
29
Meirav Pevsner-Fischer, Timur Tuganbaev, Mariska Meijer, Sheng-Hong Zhang, Zhi-Rong Zeng, Min-Hu Chen, Eran Elinav. Role of the microbiome in non-gastrointestinal cancersWorld Journal of Clinical Oncology 2016; 7(2): 200-213 doi: 10.5306/wjco.v7.i2.200
30
Andra-Iulia Suceveanu, Laura Mazilu, Andreea-Daniela Gheorghe, Anca Pantea Stoian, Felix Voinea, Adrian-Paul Suceveanu. Liver Cancer2018;  doi: 10.5772/intechopen.80527